Olaparib and Doxorubicin Co-Loaded Polypeptide Nanogel for Enhanced Breast Cancer Therapy

Although great progress has been made in improving the efficacy of cancer treatment through combination treatment using drug agents, there are still challenges in improving the efficiency of drug delivery. In this study, olaparib and doxorubicin were co-loaded on disulfide bond cross-linked polypept...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanhong, Wang, Meiyan, Liu, Wanru, Jing, Jili, Ma, Hongshuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108339/
https://www.ncbi.nlm.nih.gov/pubmed/35586554
http://dx.doi.org/10.3389/fbioe.2022.904344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108339/
https://www.ncbi.nlm.nih.gov/pubmed/35586554
http://dx.doi.org/10.3389/fbioe.2022.904344

Ejemplares similares